Topics

Glioblastoma | Treatment | Immunotherapy | Natural Killer Cells

Home > Publications > Topics > Glioblastoma > Treatment > Immunotherapy > Natural Killer Cells

Miller JC, Cao B, Shen J.
Head-to-head: IL-21 triumphs over IL-15 in NK cell therapy for glioblastoma.
Acta Biochim Biophys Sin (Shanghai). 2025 Jan 23. doi: 10.3724/abbs.2025009. PMID: 39844642. Laboratory investigation. ˍ

Tang E, Chen JY.
Shaping the glioblastoma microenvironment to enhance CAR-NK immunotherapy.
Front Immunol. 2025 Dec 1;16:1681966. doi: 10.3389/fimmu.2025.1681966. PMID: 41403931. Review. ˍ

Steuart SJ, Grewal EP, Sun J, Richardson LGK, Bulow US, Garcia-Beltran WF, Curry WT Jr, Choi BD.
Next-generation CAR-NK cell therapy for glioblastoma: strategies to overcome antigen escape and the immunosuppressive tumor microenvironment.
Expert Opin Biol Ther. 2026 May 11;26(5):437-440. doi: 10.1080/14712598.2026.2672421. PMID: 42113024. ˍ